Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 24 2024
0mins
Source: Benzinga
New Decree for Medical Cannabis in Colombia: A new decree allows the sale of dry cannabis flower in Colombia, benefiting both companies and patients, while favoring micro, small, and medium-sized enterprises (MIPYMES) based on income criteria. This shift opens up local market opportunities for many cannabis companies that previously focused on exports.
Regulatory Challenges and Opportunities: The decree introduces regulatory requirements, including sanitary authorization for dry flower, which may delay implementation. However, it also presents growth opportunities for pharmacies and aims to adapt existing Good Manufacturing Practices (GMP) certifications to include dry flower products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
